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Newmyelin sheaths can be restored to demyelinated axons in a spontaneous regenerative process called remyelination. In general, new
myelin sheaths aremade by oligodendrocytes newly generated fromawidespread population of adult CNS progenitors called oligodendrocyte
progenitor cells (OPCs).Newmyelin inCNS remyelination inboth experimentalmodels and clinical diseases canalsobe generatedbySchwann
cells (SCs), themyelin-forming cells of the PNS. Fate-mapping studies have shown that SCs contributing to remyelination in the CNS are
often derived from OPCs and appear not to be derived from myelinating SCs from the PNS. In this study, we address whether CNS
remyelinating SCs can also be generated from PNS-derived cells other thanmyelinating SCs. Using a genetic fate-mapping approach, we
have found that a subpopulation of nonmyelinating SCs identified by the expression of the transcription factor Foxj1 also contribute to
CNS SC remyelination, as well as to remyelination in the PNS. We also find that the ependymal cells lining the central canal of the spinal
cord, which also express Foxj1, do not generate cells that contribute to CNS remyelination. These findings therefore identify a previously
unrecognized population of PNS glia that can participate in the regeneration of newmyelin sheaths following CNS demyelination.
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Introduction
Remyelination is the process by which new myelin sheaths are
restored to demyelinated axons (Franklin and ffrench-Constant,
2017). In the CNS, remyelination is mediated by oligodendro-
cytes newly generated from a widespread and abundant popula-
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Significance Statement
Remyelination failure in chronic demyelinating diseases such asmultiple sclerosis drives the current quest for developingmeans
by which remyelination in CNS can be enhanced therapeutically. Critical to this endeavor is the need to understand the mecha-
nismsof remyelination, including thenature and identity of the cells capable of generatingnewmyelin sheath-forming cells.Here,
we report a previously unrecognized subpopulation of nonmyelinating Schwann cells (SCs) in the PNS, identified by the expres-
sion of the transcription factor Foxj1, which can give rise to SCs that are capable of remyelinating both PNS and CNS axons. These
cells therefore represent a new cellular target for myelin regenerative strategies for the treatment of CNS disorders characterized
by persistent demyelination.
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tion of adult multipotent progenitor cells commonly called
oligodendrocyte progenitor cells (OPCs) (Franklin and
ffrench-Constant, 2017). Somewhat counterintuitively, de-
myelinated axons in the CNS can also be remyelinated by
Schwann cells (SCs), the myelinating cells of the PNS
(Blakemore, 1975). This atypical SC remyelination of the CNS
occurs not only in experimental models of CNS demyelina-
tion, but also in a number of naturally occurring demyelinat-
ing pathologies of autoimmune, traumatic, genetic, and toxic
origin (Ghatak et al., 1973; Itoyama et al., 1983, 1985; Duncan
and Hoffman, 1997). It was originally believed that these CNS
SCs were entirely of peripheral origin, immigrating into the
damaged CNS following a breach in the astrocytic glia limitans
(Franklin and Blakemore, 1993; Duncan and Hoffman, 1997).
However, more recent genetic fate-mapping studies in which
reporter proteins are expressed exclusively with adult OPCs
have revealed that most are derived from OPCs and that very
few are derived frommyelinating SCs of the PNS (Zawadzka et
al., 2010; Assinck et al., 2017). Nevertheless, these studies do
not exclude the possibility that PNS cells other than myelinat-
ing SCs may provide a source of CNS SCs (Zujovic et al.,
2010). Even though the adult PNS does not contain a popula-
tion of progenitor cells equivalent to OPCs and PNS remyeli-
nation is often by mature SCs undergoing “dedifferentiation”
into an immature progenitor state and generate remyelinating
SCs (Jessen andMirsky, 2005, 2016), there are other cells types
that may potentially be sources of CNS SCs, especially those of
neural crest origin such as nonmyelinating SCs (Remak cells)
and endoneurial fibroblasts.
In the present study, we used an inducible Cre-Lox fate-
mapping strategy to assess the contribution of Foxj1-expressing
cells to the remyelination following lysolecithin-induced demy-
elination in the spinal cord. The original rationale for our choice
of Foxj1-Cre was to establish whether Foxj1-expressing ependy-
mal cells contribute to CNS remyelination given recent reports
of their plasticity following traumatic spinal cord injury (Me-
letis et al., 2008). Although we found no evidence of Foxj1
ependymal cells contributing to the generation of new remy-
elinating cells, we instead found expression of Foxj1 in non-
myelinating SCs and evidence that these cells are a source of
CNS remyelinating SCs.
Materials andMethods
Animals. Mice with C57BL6 background expressing Foxj1-CreERT2
(Rawlins et al., 2007), PDGFRa-CreERT2 (Rivers et al., 2008), and
Sox10-CreERT2 (Laranjeira et al., 2011; Zhao et al., 2015) were crossed
with Cre-dependent reporter mouse lines expressing farnesylated GFP
(Rawlins et al., 2009) (Rosa-CAG-fGFP) to produce double heterozy-
gous mice, denoted as Foxj1-GFP, PDGFRa-GFP, and Sox10-GFP, re-
spectively (Fig. 1A).Mice of either sex have been used in this study. For
each experimental group, three to nine animals were used; the exact
numbers used in quantification are provided in the Results section.
All animal studies were conducted under the Animals (Scientific Pro-
cedures) Act 1986 Amendment Regulations 2012 following ethical
review by the University of Cambridge Animal Welfare and Ethical
Review Body.
Tamoxifen administration and surgery. To induce Cre-mediated re-
combination, mice at the age of 7–8 weeks were administered with ta-
moxifen prepared in corn oil (Sigma-Aldrich) at 250 mg/kg daily for 4
consecutive days by oral gavage. Subsequent procedures were performed
8–10 d following the final tamoxifen administration. All surgical proce-
dures were conducted under aseptic conditions and the animals were
provided perioperative analgesia (buprenorphine 0.05 mg/kg, i.p.) and
additional care. CNS demyelination lesions were created in dorsal or
ventral spinal cord white matter by direct injection of lysolecithin as
described previously (Zhao et al., 2008). Briefly, under isoflurane anes-
thesia, the dorsal surface of thoracolumbar spinal cord was exposed by
removing the soft tissue between vertebra between T13 and L1. One
microliter of lysolecithin (1% in PBS) was injected into dorsal or ventral
funiculus via a 10 l Hamilton syringe with a fine glass tip from pulled
capillary attached.
Sciatic nerve crush and transection injuries were induced under
isoflurane anesthesia. A 0.5 cm length of mouse sciatic nerve was
exposed at the level of midfemur. A crush injury was created by
clamping the entire nerve with a pair of fine forceps (Dumont #5 at a
marked position 3 mm from the tip) for 20 s twice. Sciatic nerve
transection was conducted by cutting the nerve with a pair of fine
scissors (10.5 cm, straight). The intact contralateral nerve served as a
control.
Mice were killed by injection of 20% pentobarbital (Pentoject)
followed by transcardiac perfusion fixation with 4% paraformalde-
hyde prepared in PBS, pH 7.4. The required tissue was removed and
further immersion-fixed with the same fixative for 2 h at room tem-
perature, followed by treatment with 20% sucrose prepared in PBS at
4°C overnight. Frozen sections were cut at 12 m for image analysis
following immunohistochemistry or in situ hybridization.
Immunohistochemistry. Frozen sections of 12 m thickness were
subject to a standard protocol for immunofluorescence staining as
described previously (Zhao et al., 2008). Where required, heat-
mediated antigen retrieval was performed using a commercial antigen
retrieval solution (Sigma-Aldrich). The following antibodies were
used: goat /rabbit anti-GFP (Abcam), rabbit anti-Olig2 (Millipore),
rabbit anti-GFAP (Dako), rabbit anti-periaxin (gift from Professor
Peter Brophy or from Sigma-Aldrich), rabbit anti-S100 (Dako), rat
anti-PDGFRa (CD140a; BD Bioscience), rabbit anti-prolyl-4 hydrox-
ylase  (P4HB; Abcam), rabbit anti-HSP47 (BioVision), rabbit anti-
IBA1 (Wako), rabbit anti-smooth muscle actin (SMA; Abcam), rabbit
anti-Ki67 (Abcam), chicken anti-myelin protein zero (P0) (Abcam),
goat anti-Sox2 and goat anti-Sox10 (Santa Cruz Biotechnology), rat
anti-CD31 (BD Biosciences), rabbit anti-fibronectin (Millipore), rat
anti-L1cam (Millipore), and rabbit anti-Foxj1 (Insight Biotechnol-
ogy) Secondary antibodies against relevant primary antibodies la-
beled with either Alexa Fluor 488 or Alexa Fluor 594 were from
Thermo Fisher Scientific. The images were acquired with a Leica SP5
confocal microscope or a Zeiss Axio Observer A1 fluorescence Imag-
ing System.
In situ hybridization. Expression of Foxj1 was examined using single-
plex RNAscope in situ hybridization (chromogenic). The mouse Foxj1
probe and all reagents were obtained from ACDBio (https://acdbio.
com/) and the hybridization and visualization were performed on frozen
sections from paraformaldehyde-fixed animals according to the manu-
facturer’s protocol.
RT-PCR. Fresh pieces of spinal cord or sciatic nerve were dissected
out from normal wild-type mice 8–9 weeks old following euthanasia.
Total RNA were extracted using RNeasy mini kit and cDNA was
prepared using the QuantiTech Reverse Transcription kit (all from
Qiagen), which incorporated a genomic DNAwipe-out step. Conven-
tional PCR was performed using a commercial PCR mix (MegaMix
Blue; Cambio). PCR products from spinal cord and sciatic nerve were
verified by sequencing.
Immunoblot. Spinal cord and sciatic nerves were harvested as for
RT-PCR. Protein extraction was performed using CelLytic MT Cell
Lysis buffer (Sigma-Aldrich) supplemented with protease inhibitor
mixture. Equal amounts of protein were denatured in sample buffer
and resolved on 4–12% SDS-polyacrylamide gels (Invitrogen). Foxj1
was detected using mouse anti-foxj1 (Thermo Fisher Scientific) and
visualized with ECL Plus (GE Healthcare).
Pre-embedding immunogold labeling electron microscopy. Animals ad-
ministered with tamoxifen for fate mapping were fixed by perfusion via
the left ventricle with 3% PFA and 0.5% glutaraldehyde in PBS. After
washingwith PBS, segments of sciatic nerve and spinal cordwere embed-
ded with 4% low-melting-point agarose and sliced at 100 m on a vi-
bratome (Leica). Pre-embedding immunogold labeling was performed
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according to the manufacturer’s protocol (Aurion). Briefly, following
permeabilization and blocking, the tissue slices were incubated at 4°C
with goat anti-GFP antibody (Abcam) for 48 h, followed by ultrasmall
gold particle-conjugated anti-goat IgG (Aurion) for 48 h at 4°C. The
samples were then subjected to a standard resin-embedding protocol
incorporating a silver enhancement step after osmium tetroxide (0.5%)
treatment. The ultrathin sections were examined on a Hitachi H600
transmission electron microscope.
Quantification. Immunolabeled cells were quantified by counting the
positive cells in which the nucleus was also stained with DAPI on sec-
tions. Data are presented as mean SE as the relative proportion of two
labeled populations. A minimum of three animals have been included in
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Figure 1. Foxj1 controlled GFP expression labels cells in both the CNS and PNS. A, Diagram illustrating transgene design of Foxj1 promoter-controlled, tamoxifen-induced activation
of fGFP reporter gene expression. B–K are images from multiple immunostaining for GFP and different cell markers. GFP-expressing cells are detected in ependymal cells lining lateral
ventricles (LV; B); ependymal cells in the central canal of spinal cord (CC; C), which coexpress Sox2; and Bergmann glia in cerebellum cortex (CB; D). Foxj1-controlled GFP is also expressed
in the PNS. GFP cells are scattered between neurofilament-positive axons in spinal dorsal roots (DR) (E, transverse section), sciatic nerves (SN, F, longitudinal section), and trigeminal
nerves (TN) (G, longitudinal sections). GFP-expressing cells do not colocalize with myelinating SC markers (H, inset shows transverse view), P0 (I ), and S100 (J, transverse section).
Image in K is from a dorsal root ganglion (DRG) showing GFP-expressing cells among nerve fibers but few among neuronal cell bodies (asterisk). Occasionally, Foxj1-GFP cells surround
a DRG neuron at axonal entry zone (inset in K ). Image L illustrates immunoreactive Foxj1 cells in small number of ependymal cells in CC, which also expressed GFP (solid arrowhead).
However, not all GFP are detected with Foxj1 (open arrowhead). Nucleus-localized Foxj1 is detectable in the transverse section of ventral root (VR) of spinal cord in GFP or GFP
cells (M ). The blue color in all images is the DAPI-stained nucleus. Foxj1 protein and mRNA can be detected in peripheral nerves as well as spinal cords (SC) by Western blot and RT-PCR
(N ). Foxj1 transcript can be visualized by the sensitive RNAScope technique in sciatic nerve and spinal cord central canal (O). Scale bars in the images indicate 20m except for E, which
is 50m, and K, which is 100m.
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each experimental group. To compare cell pro-
portion in dorsal and ventral spinal roots,
transverse sections were used for cell counts,
and Student’s t test was used for statistical
analysis.
Results
Foxj1 labels CNS ependymal cells and
nonmyelinating cells in
peripheral nerve
Consistent with previous studies (Yu et
al., 2008;Muthusamy et al., 2014), tamox-
ifen administration in mice expressing
Foxj1 fate-mapping reporter construct
(Foxj1-GFP; Fig. 1A) led to induction of
GFP expression in ependymal cells lining
the cerebral ventricles and central canal in
the spinal cord (Fig. 1B,C). Labeled cells
were also found in other parts of brain
including the molecular layer of cerebel-
lum (Fig. 1D). In the spinal cord labeling
was restricted to the ependymal cells of
the central canal. Labeled cells were also
detected in dorsal and ventral spinal roots
(Fig. 1E) and throughout the sciatic and
trigeminal nerves (Fig. 1F,G). We found
on an average of 46.41 8.79% (n 9) of
ependymal cells were labeled with GFP in
tamoxifen inducible Foxj1-GFP mice.
Since Foxj1 expression appears to be high-
est in ependymal cells in the nervous sys-
tem, we expect the induction efficiency
would be similar or lower in other cell
types in CNS and peripheral nerves.
The findings prompted us to charac-
terize the distribution and identity of the
Foxj1 labeled (Foxj1) cells in the PNS
by immunohistochemistry using specific
markers for each major cell type. As illus-
trated in Figure 1, F–I, GFP cells in lon-
gitudinal sections of sciatic nerve had an
elongated morphology with oval-shaped
nuclei. These cells did not surround axons
as revealed by double immunostaining for
neurofilament, as an axonal marker (Fig.
1E–G), and did not have overlapping ex-
pression with myelinating SC-specific
markers, periaxin (PRX), myelin protein
zero (MPZ), and S100 (Fig. 1H–J), indi-
cating that the reporter protein GFP was
not expressed by myelinating SCs. Foxj1
labeled cells were occasionally found in
the dorsal root ganglia (DRG), but far less
abundantly than in peripheral nerves (Fig.
1K). We found that occasionally Foxj1-
GFP cells were present at the edge of
DRG, with processes wrapping DRG neu-
rons (Fig. 1K, inset), but these were rare.
To determine whether the Foxj1 promoter-
driven GFP expression reflected the expres-
sion of Foxj1 itself, we examined the level of
Foxj1 protein by immunohistochemistry,
Western blot, and mRNA with RT-PCR in
peripheral nerves. Immunostaining only
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Figure 2. Foxj1-GFP-labeled cells express fibroblast markers but are of a distinct population from PDGFRa-GFP labeled cells in
peripheral nerves. Immunofluorescence characterization of normal sciatic nerves (SN) from Foxj1-GFP mice treated with tamox-
ifen. Double immunostaining for GFP and variousmarkers was performed on longitudinal sections. Colocalized staining is marked
with arrowheads. Overlaid images show that Foxj1 labeled cells in SN are not associatedwith endothelial cells labeled by CD31 (A),
nor do they express the macrophage marker IBA1 (B). A proportion of GFP cells are labeled with NG2 (C) and proteins usually
expressedby fibroblasts such as fibronectin (FN,D), P4HB (E), SMA (F ), andHSP47 (G). InD–G, the split channel viewsof theboxed
area by dotted lines are shown in separate images. Foxj1-GFP-labeled cells also expressed P75NTRs (H and confocal orthogonal
view inH). GFP-labeled cells do not coexpress PDGFRa (CD140a, I ). PDGFRa fate-mapping GFP reporter mice were characterized
bydouble immunostaining. PDGFRa-GFP labeled cells are not associatedwithneurofilament-labeled axons (J ). TheGFP cells are
confirmed expressing CD140a (inset in J ) and are double labeledwith P4HB and SMA (K and inset inK ). PDGFRa-GFP-labeled cells
are also detected for P75NTR (L). Scale bar indicates 50m for all images.
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detects a smallnumberof ependymal cells in
the central canal, not in all GFP-expressing
cells (Fig. 1L). In the ventral root of the spi-
nal cord, nucleus-localized Foxj1 cells
were detected and the intensity of staining
wasweak (Fig. 1M).The lower tissue levelof
expression in sciatic nerve was consistent
with Western blot and RT-PCR compared
with spinal cord tissue (Fig. 1N). A very low
level of Foxj1mRNAexpressionwas further
confirmed with in situ hybridization using
the sensitive RNAScope technique (Fig.
1O).
Foxj1-expressing cells in peripheral
nerve are a subpopulation of
nonmyelinating SCs with
fibroblast-like features
We next performed a series of double-
labeling immunohistochemistry experi-
ments to determine the identity of
Foxj1-labeled cells in peripheral nerves. In
addition to axons and myelinating SCs,
the peripheral nerves contain endothelial
cells, pericytes, residential macrophages,
fibroblast-like cells, and nonmyelinating
SCs, which group small diameter axons
into Remak bundles. Double-labeling im-
munofluorescence staining showed that
GFP was not expressed by CD31-labeled
endothelial cells (Fig. 2A), nor by macro-
phages marked by ionized calcium-bind-
ing adapter molecule 1 (IBA1; Fig. 2B). A
proportion of Foxj1-GFP-labeled cells
(10%GFP cells)were found to express
NG2 (Fig. 2C), which has been associated
with endoneurial fibroblast-like cells in
the peripheral nerves (Richard et al., 2012,
2014). Further staining revealed that GFP
expression colocalized with a number of
other fibroblast-expressedmolecules such
as fibronectin, prolyl-4-hydroxylase B
(P4HB), smoothmuscle actin (SMA), and
heat shock protein 47 (HSP47) (Fig. 2D–
G). However, a considerable proportion
(73.4%  12.7%) of GFP cells also ex-
press the p75 neurotrophin receptor
(P75NTR) (Fig 2H,H), which is regarded
as a marker specific for SC precursors and
nonmyelinating SCs (NMSCs). Foxj1-
GFP cells did not express CD140a (Fig.
2I ), also known as platelet-derived
growth factor receptor  (PDGFRa),
which we and others have previously
shown to mark fibroblasts in peripheral
nerves (Raivich andKreutzberg, 1987; Zawadzka et al., 2010).We
compared the distribution of labeled cells in sciatic nerve of PDG-
FRa-driven fate-mapping mice and found that most PDGFRa-
GFPcells also expressedCD140a, as expected (Fig. 2J, inset), as well
as P4HB and SMA (Fig. 2K, inset). Unexpectedly, PDGFRa-GFP
cells were found to be labeled by P75 (Fig. 2L). Therefore, even
though Foxj1- and PDGFRa-labeled cells both can express fibro-
blast markers, they are mutually exclusive with regard to the ex-
pression of CD140a and therefore likely belong to separate
populations in adult peripheral nerves.
We next performed further characterization to verify whether
Foxj1 was expressed by NMSCs (Remak cells) using additional
markers. Most Foxj1-GFP-labeled cells (77.8% 5%) in normal
adult sciatic nerve colocalized with L1 cell adhesion molecule
(Fig. 3A), a protein expressed by immature myelinating cells and
NMSCs in peripheral nerves and some neurons (Nieke and
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Figure 3. Foxj1 labels nonmyelinating SCs. Images in A–F illustrate merged double immunofluorescence staining on longitu-
dinal sections of sciatic nerve (SN) from adult Foxj1-GFPmice treated with tamoxifen. Most GFP-expressing cells coexpress the L1
cell adhesion molecule, a marker of nonmyelinating SCs in peripheral nerves (A). GFP-expressing cells can also express Sox10, a
neural crest-related transcription factor (B). The single channel images of the same area in A and B marked by dotted line are
shown in image sets on the right side of themain images. PDGFRa-labeled cells (PDGFRa-GFP) in sciatic nerves do not coexpress L1
(C). Low levels of GFAP are detected in Foxj1-GFP-expressing cells (D, inset). Costaining for GFP and neurofilament reveals a close
association between GFP and small-diameter axons (arrowheads) (E). Dorsal and ventral roots (DR and VR, respectively) from
lumbar spinal cord were stained for GFP, showing greater numbers of Foxj1-GFP cells in dorsal root (F ) and this was correlated
with the proportion of L1 immunoreactivity in corresponding locations (inset in F ). G–I are images from pre-embedding immu-
nogold electron microscopy against GFP on SN from Foxj1 and Sox10 fate-mapping mice. Silver-enhanced gold particles were
mainly detected on “Remak” bundles in Foxj1-GFP samples (G),whereas themajority of gold particles in Sox10 fate-mappingmice
are deposited in SC cytoplasm around the myelinated axons but excluded from compact myelin sheaths (H ). PDGFRa labeling
identifies endoneurial fibroblast like cells (I ). Scale bars: A–E, 25m; F, 50m; G, 2m; H, I, 1m.
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Schachner, 1985; Samatov et al., 2016). No PDGFRa-GFP-
labeled cells were detected to coexpress L1 (Fig. 3C). Foxj1-GFP
cells also expressed Sox10 (Fig. 3B), a neural crest transcription
factor and pan-SC lineagemarker (Nonaka et al., 2008), as well as
glial fibrillary acidic protein (GFAP), an intermediate filament
found in NMSCs (Fig. 3D) (Jessen et al., 1990). These observa-
tions strongly suggested that Foxj1 expression labels a subpopu-
lation of NMSCs, a conclusion supported by the observations
that GFP cells were found in close association with small cali-
ber, neurofilament-positive axons in a manner that resembled
Remak bundles (Fig. 3E) and considerably more Foxj1-GFP
cells were detected in dorsal roots compared with ventral roots of
spinal cord, the former containing a higher proportion of non-
myelinated fibers (Griffin and Thompson, 2008; He et al., 2012)
(Fig. 3F). However, there was no significant difference in the
percentage of L1-expressing GFP cells between dorsal and ven-
tral spinal root (87.38 3.95%, n 5 vs 81.51 5.86, p 0.447).
Quantification showed that less than half
(40.55  10.46%, n  6) of L1 cells in
SNwere labeled for GFP, though this pro-
portion is likely under estimated consid-
ering the level of inducible recombination
efficiency.We then confirmed the expres-
sion of Foxj1 likely in NMSCs by immu-
nogold electron microscopy: the silver
enhanced gold particles conjugated with
GFP antibody were found clearly concen-
trated in Remak bundles (Fig. 3G),
whereas in Sox10-GFP mice, labeling was
mainly in the cytoplasm of myelinating
SCs (Fig. 3H). In PDGFRa-GFP mice, the
gold particles were found in NMSCs that
resembled fibroblast-like cells (Fig. 3I).
The results indicate that Foxj1-GFP
cells express markers for fibroblasts and
NMSCs, raising the possibility that either
Foxj1 labels both populations or these
marker lack specificity in peripheral
nerves. To resolve this, we further charac-
terized unlesioned peripheral nerves by
immunostaining with several selected
markers for fibroblasts and the NMSC
marker L1.Weuse L1 as anNMSCmarker
because almost all L1 cells also express
p75 (97.39  0.7%, n  6) and a similar
proportion of P75 cells expressed L1
(73.69 4.63%, n 6). Many of the L1
fraction of P75 cells exhibited a different
morphology from the typical elongated
shape of L1 cells (Fig. 4D), suggesting
that these cells may account for the
fibroblast-like population labeled by
PDGFRa (Fig. 2L). As shown in Fig. 4, L1
was coexpressed with P4HB, fibronectin,
and NG2. Quantification indicated that
the overlapping cells only accounted for
25% of L1 cells, which were colabeled
with either P4HB (25.37 6.46%, n 6)
or NG2 (16.5 5.23%, n 3). Similarly,
20% of either P4HB cells (17.21 
2.57%, n  6) or NG2 cells (17.52 
3.08%, n  3) also expressed L1. Triple-
labeled cells that were also L1 andGFP
were detected with all of the fibroblastmarkers tested. The results
confirmed that a population of NMSCs express markers used to
label fibroblasts in various tissues.
Peripheral nerve-derived Foxj1 cells but not ependymal
cells contribute to CNS SC remyelination
Next, we investigated whether Foxj1-GFP-labeled cells contrib-
ute to remyelination in the CNS.We performed spinal cord focal
demyelination by injecting lysolecithin into the white matter of
tamoxifen-treated mice. Discrete, focal lesions were created in
either the dorsal or ventral white matter funiculi of the thoraco-
lumbar spinal cord (Fig. 5A–H). Within dorsal lesions, very few
GFP-expressing cells were detected at 5, 14, and 21 d postlesions
(dpl) despite their close vicinity to the central canal in which
ependymal cells were labeled (Fig. 5A–D).However, considerable
numbers of GFP-expressing cells were present in ventral lesions
at both 14 and 21 dpl, when remyelination is in progress or near
L1P75DAPIL1 P75
L1 FN L1FNDAPI
L1 P4HB
GFP
A
B
C
L1P4HBDAPI
A’ A”
B’ B”
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L1 NG2
D D’ D”
L1NG2DAPI
Figure 4. Nonmyelinating SCs express fibroblast markers. Image sets A–C illustrate immunostaining of longitudinal sections
from unlesioned sciatic nerves for L1Cam (L1, green), a marker labeling nonmyelinating SCs, with markers labeling peripheral
nerve fibroblasts (red). The merged images show that a proportion of L1 immunoreactive cells colocalize with P4HB (A–A),
fibronectin (FN,B–B), and NG2 (C–C). Image setD shows that themajority of L1-labeled cells are also positive for P75NTR (P75)
(D andmerged imageD) andaproportionof P75 cells are not labeledwith L1. Theopenarrowheadshighlight aP75 cell that
is not labeled with L1 (D and D). The solid arrowheads in all images indicate examples of colocalization. Scale bar indicates
50m, applicable to all images.
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completion. The labeled cells were mainly
located in the center of the lesion (Fig.
5G,H). To identify the fate of GFP cells
following demyelination, we performed
immunohistochemistry for specificmark-
ers of CNS glial cells: Olig2 for oligoden-
drocyte lineage cells, GFAP for astrocytes,
and IBA1 for microglia/macrophages. No
GFP cells expressed any of these mark-
ers, indicating that Foxj1 cells do not
give rise to CNS cell types in the white
matter (Fig. 5I–K). The distribution of
GFP cells, however, resembled that pre-
viously described for remyelinating SCs
(Zawadzka et al., 2010). The majority of
the GFP-expressing cells present in the le-
sion at 14 dpl also expressed PRX (Fig.
5L,M), a marker only expressed in my-
elinating SCs (Gillespie et al., 1994;
Zawadzka et al., 2010). It is also confirmed
by double immunostaining with P0 (Fig.
5N). Therefore, Foxj1 cells can give rise
to remyelinating SCs following CNS de-
myelination. There was considerable
variation in the numbers of Foxj1-
derived SCs: among the nine mice with
ventral lesions, five contained GFP
cells in the demyelinated area. The pro-
portion of GFP-labeled PRX cells over
all PRX SCs ranged from none to
33%. An average of 54.18  12.08%
(n  5) of GFP cells in the ventral le-
sions at 14 dpl coexpressed PRX and
most of the PRXGFP cells resembled
the morphology of PRX cells (Fig. 5L).
In dorsal and some ventral spinal cord
lesions, despite of the absence of Foxj1-
labeled cells following demyelination,
remyelinating SCs were invariably de-
tected, which were most likely generated
from OPCs.
To establish the origin of Foxj1-GFP
CNS remyelinating SCs, we first investi-
gated whether theymight be derived from
Foxj1 ependymal cells. We used a
FGFR3-GFP mouse reporter line, in
which GFP is expressed by both ependymal cells and astrocytes
(Zawadzka et al., 2010). In ventral lesions, there was an abun-
dance of GFPGFAP astrocytes in and around the lesion and
surrounding a central region containing many PRX-expressing
SCs: however, none of these SCs coexpressed GFP (Fig. 6A).
Many of the GFP cells within the ventral lesion were located
around the CNS–PNS transitional region (Fig. 6L,M). This led
us to conclude that the GFP CNS remyelinating SCs in Foxj1-
GFP fate-mapping mice were derived from Foxj1 cells present
within peripheral nerves. This conclusion was supported by the
occurrence of Ki67-proliferating L1 cells in ventral roots ad-
jacent to ventral white matter lesions at 5 dpl (but not on the
contralateral unlesioned side) (Fig. 6B–D), indicating a CNS in-
jury induced response. There was no Ki67 ependymal cells
found in central canal in the spinal cords with white matter le-
sions (Fig. 6B, inset). In addition, all ventral lesions containing
Foxj1-GFP cells (five of nine animals) were directly adjacent to
ventral spinal roots in which a direct injury from the lesion in-
duction likely occurred because a small number of GFP-labeled
PRX were also found, but were not present in the contralateral
side (Fig. 6E,F).
Foxj1-expressing cells in peripheral nerves respond to
peripheral nerve injury and give rise to repair SCs
The ability of Foxj1 cells in peripheral nerve to contribute to
CNS remyelination prompted us to examine their response to
peripheral nerve injury. Following sciatic nerve crush, there was
an increase in GFP cells within lesioned area (Fig. 7A–E) asso-
ciated with the expression of the proliferation marker Ki67 (Fig.
7B, inset). At 21 and 28 d postinjury (dpi), many GFP cells dis-
played a morphology resembling myelinating SCs with distinct
appearance of cytoplasmic bands (Fig. 7D,E). Double labeling
with the myelinating SC marker PRX confirmed a close colocal-
ization (Fig. 7F). As in CNS lesions, GFP also surroundedmyelin
A
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GFPDAPI
GFPGFAPDAPI GFPOlig2DAPI GFPIBA1DAPI
GFPPRXDAPI GFPPRXDAPI
5 dpl 14 dpl 21dpl
GFPP0DAPI
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Figure5. Foxj1-labeled cells give rise to remyelinating SCs in demyelinating lesions in spinal cordwhitematter. Demyelination
lesions were induced in mice Foxj1-GFP-expressing mice by direct injection of lysolecithin in either dorsal or ventral funiculi as
shown inA and E, with corresponding images fromGFP immunostaining for 5, 14, and 21 dpl. FewGFP-expressing cells have been
detected in dorsal lesions (B–D), whereas a large number of GFP cells are found in ventral lesions from 14 dpl (F–H ). Double
immunostaining indicates that Foxj1-GFP cells do not express the astrocyte marker GFAP (I ), the oligodendrocyte lineagemarker
Olig2 (J ), nor themicroglialmarker IBA1 (K ).L shows that considerablenumbers ofGFP-expressing cells coexpress themyelinating
SC marker PRX (arrows). The box area is shown as split channels (L1 and L2) and merged in (L3).M, Orthogonal view of confocal
images of double immunostaining confirming the colocalization of GFP and PRX in ventral lesions at 14 dpl. The SC identity of
GFP cells in lesion is verifiedby colocalizationwithmyelin P0, as illustratedbyorthogonal confocal view inN. Insets in the images
showmagnified area in lesions in respective imagesmarkedwith dotted outlines, for either double staining (I–K ) or single colors
(G, L). Scale bars in B indicate 100m and apply to C, D, and F–H. Scale bar in I indicates 50m and applies to J and K. In L–N,
the scale bars indicate 25m.
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labeled with antibodies to P0 (Fig. 7G). Further staining with
neurofilament antibody confirmed GFP ensheathing axons in a
manner suggestive of myelin sheath formation (Fig. 7H). Quan-
tification of the lesion area at 28 dpi indicated that 30% of
PRX cells were also GFP and nearly 80% of GFP-labeled cells
coexpressed PRX (Fig. 7I), suggesting that most Foxj1 cells
associated with the lesion became myelinating SCs. As a control,
we performed crush injury on PDGFRa-GFP mice. There was a
considerable increase in GFP labeled cells at 28 dpi compared
with controls (Fig. 7 J,K). However, there was no overlap be-
tween GFP and PRX immunoreactivity (Fig. 7K), confirming
that PDGFRa-GFP cells did not give rise to new SCs. This obser-
vation is consistent with previous reports that PDGFRa-labeled
cells in the PNS do not make SCs (Zawadzka et al., 2010; Assinck
et al., 2017).
We further examined the response of Foxj1-labeled cells in a
sciatic nerve transectionmodel. Following transection, a connec-
tive tissue bridge forms between the proximal and distal stumps
that contains macrophages, fibroblasts, endothelial cells, and
NMSCs (McDonald et al., 2006). At 7 dpi, the numbers of Foxj1
cells were increased in the proximal and
distal stumps (Fig. 8A,C). The cells had an
elongated bipolar spindle shape and were
aligned in the direction of the nerve lon-
gitudinal axis. Foxj1 cells were present
in the bridge (Fig. 8B). The numbers of
GFP cells in the bridge were similar to
those identified in samples from Sox10-
GFP reporter mice that were also sub-
jected to nerve transection (Fig. 8D).
Because Sox10-GFP labels both myelinat-
ing and nonmyelinating SCs before injury
induction (Fig. 8E,F), one would predict
significantly more GFP cells in injury
area. That there were not suggested that
NMSCs may be the predominant SCs re-
sponding to injury at early stage following
injury. To provide direct evidence for the
relative contribution of myelinating and
nonmyelinating SCs to the regeneration
of PNS injury, definitive cell-specific fate
mapping using transgenic fate-mapping
mouse lines of equal recombination effi-
ciency would be necessary.
Discussion
Remyelination in the CNS is usually
achieved by newly generated oligoden-
drocytes derived from CNS progenitor
cells (often called OPCs). In some cir-
cumstances, especially when there is
concurrent loss of astrocytes, remyeli-
nating SCs also occur. Fate-mapping
data suggest that the predominant
source of the both new oligodendrocyte
and SCs are PDGFRa/NG2-expressing
OPCs, which are actively recruited into
the demyelinated area. Neither astro-
cytes nor mature oligodendrocytes are
sources of new remyelinating cells
(Zawadzka et al., 2010; Crawford et al.,
2016). However, other cell types may
also contribute to remyelinating cell
population, such as ependymal cells (EPCs) lining the ventri-
cles and central canal of spinal cord. In this study, we ad-
dressed the question by the genetic fate-mapping to label
Foxj1-expressing EPCs and follow their distribution at differ-
ent stages of remyelination following lysolecithin-induced de-
myelination in the spinal cord. Foxj1, a master regulator in the
formation of motile cilia, is a specific marker of ciliated cells
such as lung epithelial cells and EPCs. In this study, we found
that Foxj1 is also expressed by a population of NMSCs and that
these cells can give rise to remyelinating SCs in the CNS.
Our discovery of remyelinating CNS SCs derived from Foxj1-
expressing cells raised the question from exactly which Foxj1
population these cells originated. Several studies have reported
that EPCs in the CNS display properties of adult stem cells, re-
sponding to injuries and contributing substantially to other neu-
ral lineage cells, particularly scar-forming astrocytes (Johansson
et al., 1999; Meletis et al., 2008; Carle´n et al., 2009). These reports
suggested that EPCs may also be a source of new remyelinating
cells in CNS. However, our data argue against this prediction
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Figure 6. SC remyelination from Foxj1-GFP-labeled cells in spinal cord lesions are not derived from ependymal cells, but likely
originate from peripheral nerves. A, Demyelinated lesion at 21 dpl in ventral spinal cord white matter of a FGFR3-GFP reporter
mouse treated with tamoxifen. Image shows overlaid double immunostaining for GFP and PRX, with the dotted line marking the
boundaries of the lesion. GFP is expressed by ependymal cells lining the central canal of the spinal cord (inset). A magnified area
with in the red box in the lesion inA showing separate and overlaid channels indicating nonoverlapping expression of GFP and PRX
is shown inA,A, andA).B illustrates a ventral spinal cord lesion (white dotted line) at 5dpl immunostained for theproliferation
marker Ki67. Ki67 cells are found in the adjacent ventral roots (VR, green dotted line), but not in ependymal cells in central canal
(inset). There are no Ki67 cells in the contralateral VR (C). The Ki67 nucleus are found in L1 cells in the VR of ventral spinal
cord lesion side (D). E and F illustrate Foxj1-GFP cells colabeled with PRX in the VR of spinal cord lesion side at 14 dpl, but none in
the VR of contralateral side. Scale bars indicate 100m in A, 50m in B, and 20m in C–F.
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because, using a FGFR3 fate-mapping approach that labels EPCs
as well as astrocytes, we could not detect any remyelinating SCs
labeled in any demyelinating lesions in the spinal cord.Moreover,
no pronounced proliferation of EPCs in the central canal at the
level of focal demyelination lesions was detected. These results
lead us to conclude that, despite their stem cell characteristics and
involvement in other CNS injurymodels, EPCs in the spinal cord
do not contribute to remyelination. The reasons for the discrep-
ancy are not entirely clear. One plausible explanation could be
that there is little or no direct EPC damage in focal demyelination
model or in the experimental autoimmune encephalomyelitis
modelusedbyothers (Guoetal., 2011),whereas this is likely tooccur
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Figure 7. Foxj1-GFP-labeled cells become repair SCs following sciatic nerve injury. Sciatic nerve crush lesionswere created in adultmice expressing reporter genes and sampleswere analyzed by
immunofluorescence staining.A–D show an area of sciatic nerve in longitudinal section immunostained to reveal Foxj1-GFP-labeled cells in normal (A) and crushed nerve at 5, 14, and 21 dpi (B–D,
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in the “stab” injurymodel used to provide evidence for a significant
EPC role in regeneration (Barnabe´-Heider et al., 2010). Other stud-
ies show that, whereas there is no significant change in EPC prolif-
eration in central canal following pure demyelinating injury, this
does occur following traumatic injury (Lacroix et al., 2014) and the
involvement is dependent on direct ependymal injury (Ren et al.,
2017). It is also possible that, because different fate-mappingmouse
lines were used in this study and that by Guo et al. (2011), different
subpopulations or additional population of cells are labeled.
We conclude that the Foxj1-labeled remyelinating SCs came
from the PNS. Early studies on the presence of SCs in the demy-
elinated CNS, either in human diseases or animal models, sug-
gested that these cells were likely derived from SCs that invaded
the CNS from the PNS (Blakemore, 1975; Itoyama et al., 1983;
Dusart et al., 1992; Duncan and Hoffman, 1997; Jasmin et al.,
2000). This conclusionwas largely based on the proximity of CNS
SC remyelination to the spinal root transition zone (although SC
remyelination has also been reported in CNS areas such as the
cerebellar peduncles that are more remote from an obvious PNS
source of SCs). However, our genetic fate-mapping experiments,
which allowed tracing of prelabeled P0-expressing myelinating
SCs, showed that the contribution of existing SCs to CNS remy-
elination was minimal and that most were derived from CNS-
resident OPCs (Zawadzka et al., 2010). These findings led to the
conclusion that nearly all remyelinating cells in the CNS lesions
are of CNS origin. However, fate mapping of PNS cells using the
P0-driven reporter lines did not exclude the possibility that other
PNS cells including NMSCs might also contribute (because P0 is
largely expressed by myelinating SCs) (Jessen andMirsky, 2005).
The current studywith lineage tracing demonstrated that, follow-
ing demyelination of the ventral spinal cord, many remyelinating
SCs came from Foxj1-labeled cells from peripheral nerves. The
extent of the peripheral contribution of CNS remyelination is
location dependent, invariably occurring adjacent to the spinal
root entry zone, where the glia limitans has likely been breached
(Duncan and Hoffman, 1997). In areas relatively distant to pe-
ripheral nerves, where there is no obvious breach in the glia limi-
tans, no Foxj1-GFP expression was evident even though there
was substantial SC-mediated remyelination in the lesions, which
is therefore likely to be OPC derived. Our data also suggest that
proximity of demyelinating CNS lesions to spinal roots is likely
necessary for Foxj1 cells to contribute to CNS remyelination. In
ventral spinal cord lesions, GFP cells could not be detected
unless they were adjacent to a ventral root. Requirement of direct
injury of spinal roots may also be necessary to mobilize the
Foxj1 cells because proliferating and remyelinating Foxj1-GFP
labeled cells occur only in the ventral roots of lesion side, not on
the contralateral side.
We have provided evidence that the Foxj1-expressing cells in
peripheral nerves are a subpopulation of NMSCs. Bothmyelinat-
ing SCs andNMSCs are differentiated from SCprecursors, which
originate from neural crest stem cells (Jessen and Mirsky, 2005,
2016; Taveggia et al., 2005). In response to axonal injury, both
myelinating SCs and NMSCs undergo a cellular reprogramming
to assume an immature phenotype mediated by activation of
transcription factor c-Jun to become “repair SCs” (Bungner cells)
(Arthur-Farraj et al., 2012). Although repair SCs from the two
origins are rarely distinguishable, subtle differences in how the
two types of mature SCs respond to nerve injuries may exist.
However, establishingwhether this is the case has been hampered
by markers that unambiguously distinguish the two types of ma-
ture cell. Grafting from sensory nerves containing NMSCs into
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Figure 8. Early-appearing SC lineage cells following nerve transection are mainly NMSCs. Immunohistochemistry for GFP and PRX was performed on longitudinal sections of sciatic nerves from
mice that received transection injury. Shown is anareaofproximal stump(A), rejoiningbridge (B), anddistal stamp (C) following sciatic cut 7dpi froma tamoxifen-treatedFoxj1-GFPmouse. Staining
of GFP-expressing cells at the bridge at the same time point following transection froma Sox10-GFPmouse is shown inD. E shows an area of intact sciatic nerve fromSox10-GFPmice indicating that
both myelinating (arrows) and nonmyelinating cells (arrowheads) have been labeled by GFP. The GFP-labeled cells in Sox10-GFP sciatic nerve coexpress L1, as shown in confocal image in F,
confirming their identity as nonmyelinating SCs. Scale bars indicate 100m in A–D and 50m in E and F.
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injured motor nerves, which have few NMSCs, yields a “sensory
pattern” in growth factor expression, suggesting that injury-
activated repair SCs of NMSC origin may have different roles in
regulating the regenerative response to injury (Ho¨ke et al., 2006).
Our data support a distinctive regenerative capacity in cells de-
rived from NMSC because it is these cells that seem predomi-
nantly able to contribute to CNS remyelination. Relevant to our
study, it is clear that NMSCs do not need their own axon to be
damaged, but instead are able to respond to injury-associated
diffusible signals from damaged myelinated fibers, which elicit
proliferation ofNMSCs (Murinson andGriffin, 2004). It remains
to be established what signals generated by CNS white matter
demyelinating injury can activate and mobilize Foxj1 NMSCs in
nearby peripheral nerves.
What is the nature of the Foxj1-expressing cells in peripheral
nerves? We believe these cells to be NMSCs (based largely on the
immunoelectron microscopy evidence). However, they also ex-
press markers more commonly associated with fibroblasts such
as fibronectin, P4HB, andHSP47 (Parrinello et al., 2010) in intact
peripheral nerves and in vitro. Endoneurial fibroblasts are de-
rived from neural crest stem cells during development (Joseph et
al., 2004) and play a role in SC sorting during peripheral nerve
injury (Parrinello et al., 2010). However, their molecular identity
seems unclear and they lack specific markers (Richard et al.,
2012). The expression of NG2 and othermarkers in fibroblasts or
NMSCs has been a subject of discussion that has not been com-
pletely resolved (Martin et al., 2001; Zhang et al., 2001; Rezajooi
et al., 2004). The expression of fibroblast markers implies that
their mesenchymal features allow their regenerative capacity,
which is induced in dedifferentiated SCs following injury (Cle-
ments et al., 2017). In our studies, we were able to distinguish
between a PDGFRA fibroblast, which does not contribute to
generation of either CNS or PNS remyelinating SCs (Zawadzka et
al., 2010; Assinck et al., 2017), and a Foxj1 NMSC with fibro-
blast features, which is able to generate remyelinating SCs in both
theCNS andPNS. It cannot be excluded that the L1Foxj1 cells
may be a separate population from NMSCs and are not of PDG-
FRA fibroblast-like population in the PNS. The identification
of this population is hampered by low efficiency in transgene
induction by tamoxifen, promiscuity of fibroblast markers, and
the limitations of immunohistochemistry. However, the bound-
ary of these cell types may be naturally overlapping given that
some of them have a shared developmental origin from neural
crest progenitors. Another potential source of cells expressing
similar markers is pericytes, but they are unlikely to overlap with
the Foxj1-GFP population because our unpublished fate-
mapping data showed that PDGFRb-GFP cells did not give rise to
SCs following sciatic nerve crush. There is a population of cells
called boundary cap cells identified only in developmental spinal
roots at the boundary of CNS andPNS,which had been described
to have stem cell properties (Zujovic et al., 2010). However, these
cells are unlikely to be associated with Foxj1 cells because they
have never been found in the adult peripheral nerves and they
behave differently bymaking remyelinating oligodendrocytes in-
stead of SCs when grafted in CNS lesions (Zujovic et al., 2010,
2011).
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